Targetable Polymeric Anticancer Drugs
- 1 February 1991
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 618 (1) , 335-344
- https://doi.org/10.1111/j.1749-6632.1991.tb27253.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- Action of polymeric prodrugs based on N-(2-hydroxypropyl)-methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer-bound [125i]daunomycinJournal of Controlled Release, 1989
- Monoclonal antibody-chromophore conjugates as selective phototoxinsJournal of Controlled Release, 1989
- Cleavage of oligopeptide side-chains in N-(2-hydroxypropyl)meth-acrylamide copolymers by mixtures of lysosomal enzymesJournal of Controlled Release, 1988
- Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibodyClinical Immunology and Immunopathology, 1988
- Photoactivatable drugsTrends in Pharmacological Sciences, 1987
- Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to ratsBiochimica et Biophysica Acta (BBA) - General Subjects, 1986
- Biological properties of targetable poly[N-(2-hydroxypropyl)-methacrylamide]-antibody conjugatesJournal of Controlled Release, 1985
- Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residuesBiochimica et Biophysica Acta (BBA) - General Subjects, 1983
- Structure and properties of pharmacologically active polymersJournal of Polymer Science: Polymer Symposia, 1975